Getinge AB (GNGBY)
21.52
+0.17
(+0.80%)
USD |
OTCM |
May 03, 16:05
Getinge Market Cap: 5.861B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 5.815B |
| May 01, 2024 | 5.774B |
| April 30, 2024 | 5.774B |
| April 29, 2024 | 5.946B |
| April 26, 2024 | 5.853B |
| April 25, 2024 | 5.744B |
| April 24, 2024 | 5.815B |
| April 23, 2024 | 5.840B |
| April 22, 2024 | 5.807B |
| April 19, 2024 | 5.292B |
| April 18, 2024 | 5.172B |
| April 17, 2024 | 5.325B |
| April 16, 2024 | 5.366B |
| April 15, 2024 | 5.308B |
| April 12, 2024 | 5.210B |
| April 11, 2024 | 5.417B |
| April 10, 2024 | 5.383B |
| April 09, 2024 | 5.567B |
| April 08, 2024 | 5.594B |
| April 05, 2024 | 5.379B |
| April 04, 2024 | 5.349B |
| April 03, 2024 | 5.330B |
| April 02, 2024 | 5.262B |
| April 01, 2024 | 5.390B |
| March 28, 2024 | 5.477B |
| Date | Value |
|---|---|
| March 27, 2024 | 5.559B |
| March 26, 2024 | 5.398B |
| March 25, 2024 | 5.456B |
| March 22, 2024 | 5.355B |
| March 21, 2024 | 5.352B |
| March 20, 2024 | 5.413B |
| March 19, 2024 | 5.480B |
| March 18, 2024 | 5.434B |
| March 15, 2024 | 5.608B |
| March 14, 2024 | 5.600B |
| March 13, 2024 | 5.657B |
| March 12, 2024 | 5.518B |
| March 11, 2024 | 5.502B |
| March 08, 2024 | 5.524B |
| March 07, 2024 | 5.483B |
| March 06, 2024 | 5.347B |
| March 05, 2024 | 5.319B |
| March 04, 2024 | 5.341B |
| March 01, 2024 | 5.464B |
| February 29, 2024 | 5.377B |
| February 28, 2024 | 5.398B |
| February 27, 2024 | 5.502B |
| February 26, 2024 | 5.526B |
| February 23, 2024 | 5.499B |
| February 22, 2024 | 5.507B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.595B
Minimum
Oct 10 2019
13.29B
Maximum
Nov 15 2021
6.603B
Average
5.832B
Median
Market Cap Benchmarks
| Abliva AB | 13.44M |
| Karolinska Development AB | 69.51M |
| Calliditas Therapeutics AB | 509.94M |
| Oncopeptides AB | 23.97M |
| Olink Holding AB | 2.859B |
Market Cap Related Metrics
| PE Ratio | 27.21 |
| PS Ratio | 1.925 |
| Price to Book Value | 1.930 |
| Price to Free Cash Flow | 18.84 |
| Price | 21.52 |
| Earnings Yield | 3.67% |
| Operating PE Ratio | 15.51 |
| Normalized PE Ratio | 25.16 |